Bruker Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 48.95.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Bruker Corp is 8.43, ranking 33 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 977.20M, representing a year-over-year decrease of 0.24%, while its net profit experienced a year-over-year decrease of 8.76%.
Key Metrics
The current valuation score of Bruker Corp is 6.80, ranking 146 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -238.43, which is -135.15% below the recent high of 83.82 and -43.97% above the recent low of -343.27.
The current earnings forecast score of Bruker Corp is 7.75, ranking 115 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 43.00, with a high of 75.00 and a low of 36.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Bruker Corp is 6.74, ranking 103 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 39.88 and the support level at 31.58, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Bruker Corp is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 94.12%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 10.23M shares, representing 6.72% of shares outstanding, with 3.23% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Bruker Corp is 7.43, ranking 41 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.21. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Bruker Corp’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
